Sitemap

• Home
• About Us
  • Overview
  • Strategy
  • Our People
    • Board of Directors
    • Senior Management Team
  • History
• Research and Drug Development
  • Overview
  • Therapeutic Focus
    • Parkinson's disease (PD)
    • Rett Syndrome
    • Schizophrenia
    • Neuropathic Pain (NP)
  • Pipeline
    • Pipeline chart
    • Safinamide
    • Sarizotan
    • NW-3509
    • Ralfinamide
  • Partners
    • Our approach
    • Current partnerships
    • Licensing opportunities
    • Conferences
    • Contact
  • Publications
  • Clinical Trials
  • Patient Resources
• Investors and Media
  • News
  • Stock Information
    • Share Price
      • Historical Price Look-up
      • Share Price Table
      • Italian Financial Transaction Tax
    • Analyst coverage
    • Major shareholders
    • Advisors and investor contacts
  • Events
  • Financial Calendar
  • Shareholder FAQs
  • Corporate Governance and Structure
  • Downloads
    • Financial report and accounts
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
    • Reports, Presentations & Webcasts
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
  • Email Alerts
• Contact Us
  • Contact Us
  • Legal information
  • Careers